Publicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (9)

2019

  1. Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer

    ecancermedicalscience, Vol. 13

2017

  1. A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM)

    Clinical and Translational Oncology, Vol. 19, Núm. 5, pp. 616-624

  2. Functional proteomics outlines the complexity of breast cancer molecular subtypes

    Scientific Reports, Vol. 7, Núm. 1

  3. Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics

    PLoS ONE, Vol. 12, Núm. 6

2016

  1. Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases

    ecancermedicalscience, Vol. 10

  2. Nab-Paclitaxel in metastatic breast cancer: Defining the best patient profile

    Current Cancer Drug Targets, Vol. 16, Núm. 5, pp. 415-428

2014

  1. The Long-HER study: Clinical and molecular analysis of patients with HER2+ advanced breast cancer who become long-term survivors with trastuzumab-based therapy

    PLoS ONE, Vol. 9, Núm. 10

2012

  1. The present and future of gene profiling in breast cancer.

    Cancer metastasis reviews, Vol. 31, Núm. 1-2, pp. 41-46

2011

  1. Implication of miRNA in the diagnosis and treatment of breast cancer

    Expert Review of Anticancer Therapy, Vol. 11, Núm. 8, pp. 1265-1275